Marina Roytman, MD

Title(s)Professor, Gastroenterology - Fresno
SchoolSchool of Medicine
ORCID ORCID Icon0000-0002-3916-4278 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Mount Sinai Hospital , New York, NY06/2003Internal Medicine
    OHSU, Portland, ORMD07/2000Medicine
    University of Hawaii, Honolulu, HIBA 05/1996Chemistry
    John Burns School of Medicine , Honolulu, HI07/2012Medical Education
    Collapse Awards and Honors
    UCSF Fresno2022  - 2022Faculty Research Award
    UCSF Fresno2020  - 2020Certificate of Appreciation for participation in teaching Doctors Academy students
    University of California San Francisco-Fresno2019  - 2019Nominated for the 2019 Kaiser Award for Excellence in Teaching, Internal Medicine Residents
    AASLD and NIH2015  - 2015Herbal Dietary Supplement Induced Liver Injury Research Workshop Award, Bethesda, May 4-5, 2015
    Queen's Medical Center2011  - 2011Outstanding teaching hospitalist award
    Society of Hospital Medicine2004  - 20041st place SHM National Clinical Vignette Competition Poster Session, New Orleans
    American Medical Association2003  - 2003Physician's Recognition Award in Continuing Medical Education
    Oregon Health and Sciences University2000  - 2000MD, Cum Laude, Alpha Omega Alpha
    University of Hawaii at Manoa, Honolulu, Hawaii1990  - 1990BA with honors, Phi Beta Kappa

    Collapse Overview 
    Collapse Overview
    Marina Roytman, M.D., F.A.C.P., F.A.A.S.L.D
    Health Sciences Clinical Professor, UCSF

    Marina Roytman, M.D., FACP, FAASLD, is board certified in Internal Medicine and fellowship trained in Medical Education.

    Dr. Roytman has been a UCSF Clinical Professor and Liver Program Director at UCSF Fresno since 2017 where she teaches hepatology to Gastroenterology fellows, Internal Medicine residents, medical students and advanced practice providers. Her academic interests include non-alcoholic fatty liver disease, drug-induced liver injury, viral hepatitis and alcohol-related liver disease as documented by her publications and her role as principal investigator in multiple clinical trials. More recently, she has been involved in research in alcohol-related liver disease given the dramatic rise of it during COVID-19 pandemic. She continues to be actively involved in metabolic dysfunction associated liver disease research given that epidemic proportions portions of this condition in the United States.

    She is a n elected fellow of the American Association of Study of Liver Disease and of the American College of Physicians.

    Her hobbies include yoga, reading and creative writing. She is fluent in Russian.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Analysis of the Association between Eosinophilic Esophagitis and MASLD: Retrospective, Observational, Cohort Analysis of the National Inpatient Sample 2016-2020. J Gastrointestin Liver Dis. 2024 Sep 29; 33(3):309-315. Kohli I, Sohal A, Patel J, Roytman M. PMID: 39348570.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Renal Manifestations of Chronic Hepatitis C: A Review. J Clin Med. 2024 Sep 18; 13(18). Sohal A, Singh C, Bhalla A, Kalsi H, Roytman M. PMID: 39337023; PMCID: PMC11433393.
      View in: PubMed   Mentions:
    3. FIB-4 Reliability in Patients With Severe Obesity: Lower Cutoffs Needed? J Clin Gastroenterol. 2024 Sep 01; 58(8):825-829. Green V, Lin J, McGrath M, Lloyd A, Ma P, Higa K, Roytman M. PMID: 37983815.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Association between Helicobacter pylori infection, MASLD, and liver fibrosis in patients with severe obesity: a single-center experience. Surg Endosc. 2024 Nov; 38(11):6873-6879. Gulati A, Roytman M, Lin J, McGrath M, Klar A, Boone K, Higa K, Ma P. PMID: 39192041.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. Fungal infections in liver cirrhosis. Transl Gastroenterol Hepatol. 2024; 9:49. Iqbal H, Mehmood BF, Jones K, Sohal A, Roytman M. PMID: 39091651; PMCID: PMC11292070.
      View in: PubMed   Mentions:
    6. Leveraging opportunities for treatment/user simplicity (LOTUS): Navigating the current treatment landscape for achieving hepatitis C virus elimination among persons who inject drugs. J Viral Hepat. 2024 Jun; 31(6):342-356. Sulkowski MS, Martinez A, Tyson GL, Scholz K, Franco RA, Kohli A, Julius SF, Deming P, Fink SA, Lynch K, Roytman M, Stainbrook TR, Turner MD, Viera-Briggs M, Ramers CB. PMID: 38433561.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    7. Association of metabolic dysfunction-associated fatty liver disease with gastrointestinal infections: insights from National Inpatient Sample Database. BMJ Open Gastroenterol. 2024 Jan 17; 11(1). Patel J, Sohal A, Bains K, Chaudhry H, Kohli I, Khanna T, Dukovic D, Roytman M. PMID: 38237944; PMCID: PMC10870785.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. Hepatitis E infection: A review. World J Virol. 2023 Dec 25; 12(5):262-271. Iqbal H, Mehmood BF, Sohal A, Roytman M. PMID: 38187497; PMCID: PMC10768387.
      View in: PubMed   Mentions: 2  
    9. Author response: The impact of COVID-19 on the hospitalization and outcomes of patients with alcohol-related hepatitis. Am J Med Sci. 2024 02; 367(2):145-146. Sohal A, Chaudhry H, Roytman M, Kowdley KV. PMID: 38040247.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Vaccine-Preventable Illness Leads to Adverse Outcomes in Liver Transplant Recipients. Dig Dis Sci. 2024 Feb; 69(2):588-595. Sohal A, Kohli I, Chaudhry H, Singh I, Arora K, Kalra S, Dukovic D, Roytman M. PMID: 38030833.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    11. Unusual sites of hepatocellular carcinoma metastasis: Case report. SAGE Open Med Case Rep. 2023; 11:2050313X231211709. Chaudhry H, Sohal A, Iqbal H, Chaudhary U, Roytman M. PMID: 38022862; PMCID: PMC10647942.
      View in: PubMed   Mentions:
    12. Recent Trends in Palliative Care Utilization in Patients With Decompensated Liver Disease: 2016-2020 National Analysis. J Palliat Med. 2024 03; 27(3):335-344. Sohal A, Chaudhry H, Sharma R, Dhillon N, Kohli I, Singla P, Arora K, Dukovic D, Verma M, Roytman M. PMID: 37851991.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Impact of COVID-19 pandemic on alcohol-related hepatitis admissions: Analysis of nationwide data 2016-2020. Am J Med Sci. 2023 09; 366(3):209-218. Sohal A, Chaudhry H, Patel J, Dhillon N, Kohli I, Dukovic D, Roytman M, Kowdley KV. PMID: 37315782; PMCID: PMC10259164.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    14. Frailty as a risk-stratification tool in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS). J Frailty Sarcopenia Falls. 2023 Jun; 8(2):83-93. Sohal A, Chaudhry H, Kohli I, Arora K, Patel J, Dhillon N, Singh I, Dukovic D, Roytman M. PMID: 37275658; PMCID: PMC10233326.
      View in: PubMed   Mentions: 1  
    15. Alcohol-related hepatitis: A review article. World J Gastroenterol. 2023 May 07; 29(17):2551-2570. Chaudhry H, Sohal A, Iqbal H, Roytman M. PMID: 37213401; PMCID: PMC10198060.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. A Complex Diagnosis of Ampullary Adenocarcinoma Presenting As Decompensated Cirrhosis. Cureus. 2023 Apr; 15(4):e37566. Iqbal H, Petrosyan A, Yoon J, Roytman M. PMID: 37193458; PMCID: PMC10183155.
      View in: PubMed   Mentions:
    17. Refractory gastric ulcer bleeding responsive to long-term octreotide. SAGE Open Med Case Rep. 2023; 11:2050313X231164856. Iqbal H, Maharaj D, Chaudhry H, Gulati A, Roytman M. PMID: 37051262; PMCID: PMC10084531.
      View in: PubMed   Mentions:
    18. Development of Liver Cancers as an Unexpected Consequence of Anabolic Androgenic Steroid Use. Cureus. 2023 Jan; 15(1):e34357. Khalid S, Laput G, Khorfan K, Roytman M. PMID: 36874750; PMCID: PMC9975287.
      View in: PubMed   Mentions: 1  
    19. Iron Man: Non-HFE Hemochromatosis Without Significant Fibrosis. ACG Case Rep J. 2023 Jan; 10(1):e00982. Chaudhry H, Sohal A, Petrosyan A, Laput G, Roytman M, Prajapati D. PMID: 36713280; PMCID: PMC9875996.
      View in: PubMed   Mentions:
    20. A tough pill to swallow: Two cases of statin-induced necrotizing autoimmune myopathy manifesting as dysphagia and transaminitis. SAGE Open Med Case Rep. 2023; 11:2050313X221150583. Chaudhry H, Lin J, Atefi R, Hagino J, Yuvienco CM, Roytman M. PMID: 36686203; PMCID: PMC9850117.
      View in: PubMed   Mentions: 3  
    21. Soaring rates of alcohol-related hepatitis in the latter phase of the COVID-19 pandemic: A new normal? JGH Open. 2023 Feb; 7(2):148-151. Sohal A, Khalid S, Green V, Hagino J, Chaudhry H, Gulati A, Roytman M. PMID: 36852146; PMCID: PMC9958332.
      View in: PubMed   Mentions: 2  
    22. Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study. Hepatol Commun. 2023 01 01; 7(1):e8874. Aby ES, Moafa G, Latt N, Sultan MT, Cacioppo PA, Kumar S, Chung RT, Bloom PP, Gustafson J, Daidone M, Reinus Z, Debes JD, Sandhu S, Sohal A, Khalid S, Roytman M, Catana AM, Wegermann K, Carr RM, Saiman Y, Kassab I, Chen VL, Rabiee A, Rosenberg C, Nguyen V, Gainey C, Zhou K, Chavin K, Lizaola-Mayo BC, Chascsa DM, Varelas L, Moghe A, Dhanasekaran R. PMID: 36633476; PMCID: PMC9827967.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. A Head Scratcher: Hepatocellular Carcinoma Manifesting as a Subcutaneous Scalp Lesion. ACG Case Rep J. 2022 Aug; 9(8):e00821. Lin J, Chaudhry H, Gill A, Roytman M, Prajapati D, Slater D. PMID: 36016859; PMCID: PMC9398777.
      View in: PubMed   Mentions:
    24. Predictors of leaving against medical advice in patients with alcohol-related hepatitis. Ann Gastroenterol. 2022 Sep-Oct; 35(5):541-546. Sohal A, Chaudhry H, Bains K, Dhaliwal A, Sharma R, Gupta G, Singla P, Dukovic D, Sandhu S, Roytman M. PMID: 36061158; PMCID: PMC9399570.
      View in: PubMed   Mentions: 1  
    25. Role of endoscopic evaluation prior to diagnostic transesophageal echocardiography: Is it necessary? JGH Open. 2022 Sep; 6(9):595-598. Sandhu S, Alhankawi D, Roytman M, Jain R, Prajapati D. PMID: 36091317; PMCID: PMC9446391.
      View in: PubMed   Mentions: 2  
    26. Seasonal Variations of Hospital Admissions for Alcohol-Related Hepatitis in the United States. Gastroenterology Res. 2022 Apr; 15(2):75-81. Sohal A, Bains K, Dhaliwal A, Chaudhry H, Sharma R, Singla P, Gupta G, Dukovic D, Sandhu S, Roytman M, Tringali S. PMID: 35572478; PMCID: PMC9076155.
      View in: PubMed   Mentions: 1  
    27. Treatment-Resistant Hepatitis C Viral Infection: A Case Report and Literature Review. Case Reports Hepatol. 2022; 2022:3556780. Green V, Roytman M. PMID: 35309181; PMCID: PMC8933098.
      View in: PubMed   Mentions: 1  
    28. The Pandemic Within the Pandemic: Unprecedented Rise in Alcohol-related Hepatitis During the COVID-19 Pandemic. J Clin Gastroenterol. 2022 03 01; 56(3):e171-e175. Sohal A, Khalid S, Green V, Gulati A, Roytman M. PMID: 34653062; PMCID: PMC8843054.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsPHPublic Health
    29. A Devastating Case of Hepatitis C-Induced Mixed Cryoglobulinemia. Case Reports Hepatol. 2021; 2021:8244432. Khalid S, Alhankawi D, Kaur K, Ali A, Kazaryan A, Roytman M. PMID: 34659845; PMCID: PMC8519709.
      View in: PubMed   Mentions: 1  
    30. Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy management. J Community Hosp Intern Med Perspect. 2021; 11(5):722-726. Sohal A, Green V, Sandhu S, Roytman M. PMID: 34567473; PMCID: PMC8462881.
      View in: PubMed   Mentions: 1  
    31. Persistent Encephalopathy in a Noncirrhotic Patient: Do not Shun This Shunt. ACG Case Rep J. 2020 Dec; 7(12):e00493. Kassamali F, Hu S, Roytman M. PMID: 33324712; PMCID: PMC7725256.
      View in: PubMed   Mentions:
    32. Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2021 Jul; 19(7):1469-1479.e19. Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen VL, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin KD, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch AD, Viveiros K, Chan W, Chascsa DM, Kwo P, Dhanasekaran R. PMID: 32950749; PMCID: PMC7497795.
      View in: PubMed   Mentions: 135     Fields:    Translation:Humans
    33. Update on the management of gastrointestinal varices. World J Gastrointest Pharmacol Ther. 2019 Jan 21; 10(1):1-21. Boregowda U, Umapathy C, Halim N, Desai M, Nanjappa A, Arekapudi S, Theethira T, Wong H, Roytman M, Saligram S. PMID: 30697445; PMCID: PMC6347650.
      View in: PubMed   Mentions: 25  
    34. Endoscopic ultrasound guided gallbladder drainage - is it ready for prime time? World J Gastrointest Pharmacol Ther. 2018 Dec 05; 9(6):47-54. Boregowda U, Umapathy C, Nanjappa A, Wong H, Desai M, Roytman M, Theethira T, Saligram S. PMID: 30568842; PMCID: PMC6288492.
      View in: PubMed   Mentions: 8  
    35. Botanicals and Hepatotoxicity. Clin Pharmacol Ther. 2018 09; 104(3):458-469. Roytman MM, Poerzgen P, Navarro V. PMID: 29920648.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsPHPublic Health
    36. Urgent Liver Transplantation for Dietary Supplements: An Under-Recognized Problem. Transplant Proc. 2017 Mar; 49(2):322-325. Wong LL, Lacar L, Roytman M, Orloff SL. PMID: 28219592.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. An Unusual Cause of Altered Mental Status in Multiple Myeloma: An Extraosseous Manifestation. Hawaii J Med Public Health. 2016 04; 75(4):109-12. Jaruvongvanich V, Spanuchart I, O-Charoen P, Kitamura C, Sumida L, Roytman M. PMID: 27099806; PMCID: PMC4832878.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    38. Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry. Hepatol Int. 2016 Jul; 10(4):616-23. Roytman M, Ramkissoon R, Wu C, Hong L, Trujillo R, Huddleston L, Poerzgen P, Seto T, Wong L, Tsai N. PMID: 27026431; PMCID: PMC5612775.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    39. Real-world Experience with Sofosbuvir-based Regimens for Chronic Hepatitis C, Including Patients with Factors Previously Associated with Inferior Treatment Response. Hawaii J Med Public Health. 2015 Sep; 74(9 Suppl 2):3-7. Wu CJ, Roytman MM, Hong LK, Huddleston L, Trujillo R, Cheung A, Poerzgen P, Tsai NC. PMID: 26793407; PMCID: PMC4582387.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    40. Autoimmune Hepatitis in Hawai'i. Hawaii J Med Public Health. 2015 Aug; 74(8):270-4. Kim TI, Kagihara JE, Tsai NC, Roytman MM. PMID: 26279964; PMCID: PMC4536739.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Poor Sustained Virological Response in a Multicenter Real-Life Cohort of Chronic Hepatitis C Patients Treated with Pegylated Interferon and Ribavirin plus Telaprevir or Boceprevir. Dig Dis Sci. 2015 Apr; 60(4):1045-51. Vo KP, Vutien P, Akiyama MJ, Vu VD, Ha NB, Piotrowski JI, Wantuck J, Roytman MM, Tsai N, Cheung R, Li J, Nguyen MH. PMID: 25821099.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    42. Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am J Gastroenterol. 2014 Aug; 109(8):1296-8. Roytman MM, Pörzgen P, Lee CL, Huddleston L, Kuo TT, Bryant-Greenwood P, Wong LL, Tsai N. PMID: 25091255.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    43. Trial and error: investigational drug induced liver injury, a case series report. Hawaii J Med Public Health. 2013 Sep; 72(9 Suppl 4):30-3. Marumoto A, Roytman MM, Tsai NC. PMID: 24052916; PMCID: PMC3764585.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    44. New triple therapy for chronic hepatitis C: real life clinical experience in a community setting. Hawaii J Med Public Health. 2013 Sep; 72(9 Suppl 4):6-13. Akiyama MJ, Piotrowski JI, Roytman MM, Chan SM, Hong LK, Huddleston L, Trujillo R, Tsai NC. PMID: 24052911; PMCID: PMC3764547.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    45. Comparison of practice patterns of hospitalists and community physicians in the care of patients with congestive heart failure. J Hosp Med. 2008 Jan; 3(1):35-41. Roytman MM, Thomas SM, Jiang CS. PMID: 18257099.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    Marina's Networks
    Concepts (115)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.